Fluad
Showing 1 - 25 of 64
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults
Recruiting
- Influenza
- +2 more
- Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4)
- High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4)
-
Oakland, CaliforniaKaiser Permanente Northern California (entire region)
Sep 1, 2023
Safety Markers of Adjuvanted Influenza Vaccine Trial in Ghent (Fluad, Saline)
Completed
- Safety Markers of Adjuvanted Influenza Vaccine
- Fluad
- Saline
-
Ghent, East-Flanders, BelgiumCenter for Vaccinology
Dec 19, 2022
Flu Trial in Cleveland (Fluad Vaccine, Fluzone HD Vaccine)
Active, not recruiting
- Flu
- Fluad Vaccine
- Fluzone HD Vaccine
-
Cleveland, Ohio
- +1 more
May 20, 2022
Influenza Trial in Lima (FLUAD Quadrivalent, FluQuadri)
Active, not recruiting
- Influenza
- FLUAD Quadrivalent
- FluQuadri
-
Lima, Peru
- +1 more
Sep 19, 2023
Pain, Quality of Life, Injection Site Reaction Trial in Durham (FLUAD® Quadrivalent, Fluzone® HD Quadrivalent, SHINGRIX®)
Recruiting
- Pain
- +3 more
- FLUAD® Quadrivalent
- +2 more
-
Durham, North CarolinaDuke University
Jan 19, 2023
Influenza Trial in New Haven (Fluzone, Fluad)
Not yet recruiting
- Influenza
- Fluzone
- Fluad
-
New Haven, Connecticut
- +1 more
Mar 15, 2022
Influenza Trial in Saint Louis (mRNA-1010, Egg-based Quadrivalent Influenza Vaccine, Adjuvanted Quadrivalent Influenza Vaccine)
Recruiting
- Influenza
- mRNA-1010
- +3 more
-
Saint Louis, MissouriWashington University in St. Louis
Nov 4, 2022
Flu Vaccine Trial in Nashville (Fluzone-High Dose Quadrivalent, Fluad, Flublock)
Completed
- Flu Vaccine
- Fluzone-High Dose Quadrivalent
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jun 16, 2022
Coadministration of Influenza Vaccination With Booster Dose of
Completed
- Co-administration of COVID-19 and Influenza Vaccines
- COMIRNATY
-
Roma, RM, ItalyFondazione Policlinico Gemelli
Mar 10, 2023
Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, FLU vaccine)
Active, not recruiting
- Respiratory Syncytial Virus Infections
- RSVPreF3 OA investigational vaccine
- FLU vaccine
-
Edegem, Belgium
- +33 more
Dec 7, 2022
Influenza, Hepatitis A, Typhoid Trial in Stanford (Fluzone® quadrivalent, Fluzone High Dose, Fluad)
Active, not recruiting
- Influenza
- +3 more
- Fluzone® quadrivalent
- +5 more
-
Stanford, CaliforniaStanford LPCH Vaccine Program
Dec 12, 2022
Influenza Trial in Rochester (Fluad Vaccine, Fluzone High-Dose)
Active, not recruiting
- Influenza
- Fluad Vaccine
- Fluzone High-Dose
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 22, 2021
Influenza Trial in Canada (aTIV Primer, QIV Primer, aTIV Booster)
Completed
- Influenza
- aTIV Primer
- +3 more
-
Vancouver, British Columbia, Canada
- +3 more
Jan 28, 2022
Does Repeat Influenza Vaccination Constrain Influenza Immune
Recruiting
- Influenza, Human
- SARS-CoV-2 Infection
- Influenza vaccination: Fluarix Tetra, Vaxigrip Tetra, Fluquadri, Fluad Quad, Afluia Quad, Flucelvax Quad
- SARS-CoV-2 vaccination: Comirnaty or Vaxzevria
-
New Lambton Heights, New South Wales, Australia
- +5 more
Nov 7, 2022
SARS-CoV-2, Seasonal Influenza, Respiratory Syncytial Virus Trial in United States (mRNA-1273, mRNA-1010, mRNA-1345)
Recruiting
- SARS-CoV-2
- +3 more
- mRNA-1273
- +4 more
-
Hollywood, Florida
- +7 more
May 25, 2022
Influenza Trial in Oxford (MF59 - ATIV)
Completed
- Influenza
- MF59 - ATIV
-
Oxford, United KingdomOxford Vaccine Group, Centre for Clinical Vaccinology and Tropic
Nov 26, 2021
Influenza, Influenza-like Illness Trial in Norfolk (adjuvanted trivalent influenza vaccine, trivalent influenza vaccine)
Active, not recruiting
- Influenza
- Influenza-like Illness
- adjuvanted trivalent influenza vaccine
- trivalent influenza vaccine
-
Norfolk, VirginiaInsight Therapeutics, LLC
May 13, 2021
Influenza, Human Trial in Georgia, Turkey (aQIV, QIV)
Not yet recruiting
- Influenza, Human
- aQIV
- QIV
-
Batumi, Georgia
- +16 more
Oct 11, 2023
Pandemic Influenza Disease Trial in Tampere, München (Placebo (PL), Trivalent influenza virus vaccine (TIV), Adjuvanted
Completed
- Pandemic Influenza Disease
- Placebo (PL)
- +3 more
-
Tampere, Finland
- +1 more
Apr 22, 2021
Influenza Trial in Canada, United States (High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 µg (split-virion, inactivated),
Completed
- Influenza
- High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 μg (split-virion, inactivated)
- +4 more
-
San Diego, California
- +15 more
Mar 24, 2022
Influenza, Human Trial in Estonia, Germany, United States (aQIV, Comparator QIV)
Active, not recruiting
- Influenza, Human
- aQIV
- Comparator QIV
-
Mobile, Alabama
- +28 more
Jul 26, 2022
Immune Response Trial in Marshfield (High Dose Influenza vaccine, Adjuvanted Influenza vaccine, Standard Dose Influenza vaccine)
Completed
- Immune Response
- High Dose Influenza vaccine
- +3 more
-
Marshfield, WisconsinMarshfield Clinic - Marshfield Center
Dec 3, 2019
Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine
Not yet recruiting
- Influenza, Human
- ARCT-2138
- +2 more
-
Brisbane, Queensland, AustraliaNucleus Network Brisbane Clinic
Nov 8, 2023
Influenza Trial (Unadjuvanted seasonal influenza vaccine, SWE adjuvant mixed with unadjuvanted seasonal influenza vaccine
Not yet recruiting
- Influenza
- Unadjuvanted seasonal influenza vaccine
- +2 more
- (no location specified)
Mar 16, 2022